Healthcare & Life Sciences
Kanso Diagnostics
Israel
unknownseries-c-plus
series-c-plus
Stage
2020
Founded
2
Investors
About
Kanso Diagnostics develops affordable, lab-grade, rapid point-of-care molecular diagnostic tests for detecting sexually transmitted infections and antimicrobial resistance.
Explore Kanso Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.